Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 2, 2003, Pages 291-297

  Barker, J E ^a   Schuldt, A J T ^a   Lessard, M D ^a   Jude, C D ^a   Vogler, C A ^b   Soper, B W ^a  

^a JACKSON LABORATORY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; GLYCOSAMINOGLYCAN;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CELL PROLIFERATION; CELL TRANSPLANTATION; CHIMERA; FETUS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; MOUSE; MUCOPOLYSACCHARIDOSIS TYPE 7; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STORAGE DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; GENE OVEREXPRESSION; HOST; MORQUIO SYNDROME; UTERUS;

ANIMALIA; MURINAE;

EID: 0347383862     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00134-7     Document Type: Article

References (35)

1. Sands M.S., Barker J.E., Vogler C., Levy B., Gwynn B., Galvin N., Sly W.S., Birkenmeier E. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 68:1993;676-686.
2. Shields L.E., Lindton B., Andrews R.G., Westgren M. Fetal hematopoietic stem cell transplantation a challenge for the twenty-first century . J. Hematother. Stem Cell Res. 11:2002;617-631.
3. Flake A.W., Roncarolo M.G., Puck J.M., Almeida-Porada G., Evans M.I., Johnson M.P., Abella E.M., Harrison D.D., Zanjani E.D. Treatment of X-linked severe combined immunodeficienty by in utero transplantation of paternal bone marrow. N. Engl. J. Med. 335:1996;1806-1810.
4. Wengler G.S., Lanfranchi A., Frusca T., Verardi R., Neva A., Brugnoni D., Giliani S., Fiorini M., Mella P., Guandalini F., Mazzolari E., Pecorelli S., Notarangelo L.D., Porta F., Ugazio A.G. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet. 348:1996;1484-1487.
5. Touraine J.L., Raudrant D., Laplace S., Gebuhrer L. Stem cell transplants in utero for genetic diseases treatment and a model for induction of immunologic tolerance . Transplant. Proc. 31:1999;681-682.
6. Blazar B.R., Taylor P.A., Vallera D.A. In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood. 86:1995;4353-4366.
7. Casal M.L., Wolfe J.H. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpressioon of β-glucuronidase can delay onset of clinical signs. Blood. 97:2001;1625-1634.
8. Donahue J., Gilpin E., Young D., Carrier E. Postnatal cytokines and boosts improve chimerism and hematological parameters in beta-thalassemic mice transplanted in utero. Transplantation. 71:2001;1491-1494.
9. Fleischman R.A., Mintz B. Development of adult bone marrow stem cells in H-2-compatible and -incompatible mouse fetuses. J. Exp. Med. 159:1984;731-745.
10. Howson-Jan K., Matloub Y.H., Vallera D.A., Blazar B.R. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients. Transplantation. 56:1993;709-716.
11. Hayashi S., Peraneau W.H., Shaaban A.F., Flake A.W. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood. 100:2002;804-812.
12. Birkenmeier E.H., Davisson M.T., Beamer W.G., Ganschow R.E., Vogler C.A., Gwynn B., Lyford K.A., Maltais L.M., Wawrzyniak C.J. Murine mucopolysaccharidosis type VII characterization of a mouse with β-glucuronidase deficiency . J. Clin. Invest. 83:1989;1258-1266.
13. v mice with limiting dilutions of +/+ donor marrow cells. Proc. Natl. Acad. Sci. USA. 85:1998;7332-7335.
14. Birkenmeier E.H., Barker J.E., Vogler C.A., Kyle J.W., Sly W.S., Gwynn B., Levy B., Pegors C. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood. 78:1991;3081-3092.
15. Barker J.E., Deveau S., Lessard M., Hamblen N., Vogler C., Levy B. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mucopolysaccharidosis type VII. Blood Cells Mol. Dis. 27:2001;861-873.
16. Harrison D.E., Astle C.M. Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice models for human umbilical cord blood . Blood. 90:1997;174-181.
17. Taylor P.A., McElmurry R.T., Lees C.J., Harrison D.E., Blazar B.R. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood. 99:2002;1870-1872.
18. Soper B.W., Lessard M.D., Vogler C.A., Levy B., Beamer W.G., Sly W.S., Barker J.E. Non-ablative neonatal marrow transplantation attenuates functional and physical defects of β-glucuronidase deficiency. Blood. 97:2001;1498-1504.
19. Wolfe J.H., Sands M.S. Murine mucopolysaccharidosis type VII a model system for somatic gene therapy of the central nervous system . Lowenstein P.R., Enquist L.W. Protocols for Gene Transfer in Neurological Disorders. 1996;263-274 Wiley, Chichester.
20. Eppig J.J., Kozak L.P., Eicher E.M., Stevens L.C. Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature. 269:1977;517-518.
21. Soper B.W., Duffy T.M., Vogler C.A., Barker J.E. A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells. Exp. Hematol. 27:1999;1691-1704.
22. Vogler C., Birkenmeier E.H., Sly W.S., Levy B., Pegors C., Kyle J.W., Beamer W.G. A murine model of mucopolysaccharidosis VII gross and microscopic findings in beta-glucuronidase-deficient mice . Am. J. Pathol. 136:1990;207-217.
23. Soper B.W., Pung A.W., Vogler C.A., Grubb J.H., Sly W.S., Barker J.E. Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses. Pediatr. Res. 45:1999;180-186.
24. Vogler C., Levy B., Galvin N.J., Thorpe C., Sands M.S., Barker J.E., Baty J., Birkenmeier E.H. Enzyme replacement in murine mucopolysaccharidosis type VII neuronal and glial response to β-glucruonidase requires early initiation of enzyme replacement therapy . Pediatr. Res. 45:1999;838-844.
25. Russell E.S., Neufeld E.F., Higgins C.T. Comparison of normal blood picture of young adults from 18 inbred strains of mice. Proc. Soc. Exp Biol. Med. 78:1951;761-766.
26. Cowan M., Tarantal A., Capper J., Harrison M., Garovoy M. Long term engraftment of T cell depleted parental marrow transplanted into fetal rhesus monkeys. Bone Marrow Transplant. 17:1996;1157-1165.
27. Rubin J.P., Cober S.R., Butler P.E., Randolph M.A., Gazelle G.S., Ierino F.L., Sachs D.H., Lee W.P. Injection of allogeneic bone marrow cells into the portal vein of swine in utero. J. Surg. Res. 95:2001;188-194.
28. Donahue J., Gilpin E., Lee T.H., Busch M.P., Croft M., Carrier E. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation. Transplantation. 71:2001;359-368.
29. Zanjani E.D., Srour H.F., Hoffman R. Retention of long-term repopulating ability of xenogeneic transplanted purified adult human bone marrow hematopoietic stem cells in sheep. J. Lab. Clin. Med. 126:1995;24-29.
30. Shaaban A.F., Kim H.B., Milner R., Flake A.W. A kinetic model for the homing and migration of prenatally transplanted marrow. Blood. 94:1999;3251-3257.
31. Barker J.E., Kaysser-Kranich T.M., Hamblen N., Deveau S. Multiple high cell dose injections of normal marrow into newborn jaundiced mice dramatically prolong life despite transient repopulation. Exp. Hematol. 27:1999;966-971.
32. Wandersee N.J., Lee J.C., Deveau S.A., Barker J.E. Reduced incidence of thrombosis in mice with hereditary spherocytosis following neonatal treatment with normal hematopoietic cells. Blood. 97:2001;3972-3975.
33. Rao S.S., Peters S.O., Crittenden R.B., Stewart F.M., Ramshaw H.S., Quesenberry P.J. Stem cell transplantation in the normal nonmyeloablated host relationship between cell dose, schedule, and engraftment . Exp. Hematol. 25:1997;114-121.
34. Barker J.E., McFarland E.C. A method to enrich mouse hematopoietic stem cells. Blood. 62:1983;827-831.
35. Bamback B.J., Mosscr K., Blakemore K., Corson V.L., Griffin C.A., Noga S.J., Perlman E.J., Zuckerman R., Wenger D.A., Jones R.J. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant. 19:1997;399-402.